CUAMC
SAGE

China Universal Asset Management Company’s Sage Therapeutics SAGE Stock Holding History

China Universal Asset Management Company’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,577
Closed -$115K – 503
2025
Q2 		$115K Buy
12,577
+245
+2% +$1.8K 0.01% 355
2025
Q1 		$98K Sell
12,332
-639
-5% -$4.68K 0.01% 356
2024
Q4 		$70.4K Buy
12,971
+1,229
+10% +$7.51K 0.01% 425
2024
Q3 		$84.8K Buy
11,742
+4,672
+66% +$42.8K 0.01% 366
2024
Q2 		$76.8K Sell
7,070
-4,484
-39% -$57.5K 0.01% 318
2024
Q1 		$217K Buy
11,554
+4,617
+67% +$106K 0.03% 279
2023
Q4 		$150K Buy
6,937
+5,406
+353% +$107K 0.03% 236
2023
Q3 		$31.5K Buy
1,531
+748
+96% +$21.6K 0.01% 263
2023
Q2 		$36.8K Sell
783
-26
-3% -$1.29K 0.01% 223
2023
Q1 		$33.9K Buy
809
+204
+34% +$8.77K 0.01% 180
2022
Q4 		$23.1K Buy
605
+49
+9% +$1.87K 0.01% 167
2022
Q3 		$22K Buy
+556
New +$21.5K 0.01% 152

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

China Universal Asset Management Company's SAGE Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 12,577 shares — an estimated $115K sold.

China Universal Asset Management Company first reported a position in SAGE in Q3 2022 and held it in 12 quarters. The position peaked at $217K in Q1 2024. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • China Universal Asset Management Company reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 12,577 Sage Therapeutics shares in Q3 2025, an estimated $115K.
  • China Universal Asset Management Company first reported a position in Sage Therapeutics in Q3 2022 and held it in 12 quarters.
  • China Universal Asset Management Company's Sage Therapeutics position peaked at $217K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.